StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NYSE · HIMS·Healthcare

Hims & Hers Health, Inc. Stock Analysis & AI Score

Hims & Hers Health, Inc. (HIMS) has an ST Score of 26.6 (D+), driven by its Growth (B) and held back by its Sentiment (D-). Analysts rate it Hold with a $32.17 price target (+9.9% upside).

Market Closed
$29.28
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
27
ST Score
26.6/100D+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date—
Website—
Country—
ExchangeNYSE

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

HIMS
26.6out of 100
Grade D+

Hims & Hers Health, Inc. (HIMS) has an ST Score of 26.6 (D+), driven by its Growth (B) and held back by its Sentiment (D-). Analysts rate it Hold with a $32.17 price target (+9.9% upside).

Strongest
GrowthB
Weakest
SentimentD-
All factor grades
  • GrowthB
  • ForecastC+
  • MomentumC-
  • ValuationD
  • ProfitabilityD
  • Financial StrengthD
  • SentimentD-
  • Piotroski2/9
Score methodology
Press Releases

Contact

HIMS stock: frequently asked questions

What is HIMS's ST Score?

Hims & Hers Health, Inc. (HIMS) has an ST Score of 26.6 (D+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is HIMS a buy, hold, or sell?

Analysts rate HIMS a Hold, with a price target of $32.17 (+9.9% vs the current price). Our ST Score grades it D+ (26.6/100). The ST Score is a data-driven signal, not a recommendation.

What are HIMS's factor grades?

Valuation D, Profitability D, Financial Strength D, Momentum C-, Growth B, Forecast C+, Sentiment D-.

What is HIMS's valuation grade?

Hims & Hers Health, Inc. (HIMS) earns a valuation grade of D, measured against Medical - Care Facilities peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is HIMS's growth grade?

Hims & Hers Health, Inc. (HIMS) earns a growth grade of B, measured against Medical - Care Facilities peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is HIMS's profitability grade?

Hims & Hers Health, Inc. (HIMS) earns a profitability grade of D, measured against Medical - Care Facilities peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is HIMS's financial strength grade?

Hims & Hers Health, Inc. (HIMS) earns a financial strength grade of D, measured against Medical - Care Facilities peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for HIMS?

The average analyst price target for Hims & Hers Health, Inc. (HIMS) is $32.17 from 20 analysts, which is +9.9% versus the recent price of $29.28.

What is HIMS's Piotroski score?

Hims & Hers Health, Inc. (HIMS) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.